Not recruitingEUCTR 2009-014469-19
OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: A randomised, double-blind, 2x2 factorial trial
This historical record does not confirm current site availability.
Historical research recordMultiple countries
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Finland · Italy and 1 more location
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- 334
- Sponsor
- University of Oxford [...] 1. University of Oxford 2.
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom, Finland, Italy
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2009-014469-19
- Official title
Show the full official title
OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: A randomised, double-blind, 2x2 factorial trial
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Finland · Italy · United Kingdom
Registry details
Historical country statuses
- Finland — Completed
- United Kingdom — Completed
- Italy — Prematurely Ended
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Oxford [...] 1. University of Oxford 2., a university.
Is this study still recruiting?
The historical registry lists this study as not recruiting.
